<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-32 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-32</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-32</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-3.html">extraction-schema-3</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of the role of older age groups (older children, adolescents, adults) in poliovirus transmission in Pakistan, including evidence for or against their involvement, study types, age group definitions, key findings, vaccination status, and any interventions or counterpoints.</div>
                <p><strong>Paper ID:</strong> paper-2b2c1f5ac5099b382c377fe97bf082ea03b0be0a</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/2b2c1f5ac5099b382c377fe97bf082ea03b0be0a" target="_blank">Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan</a></p>
                <p><strong>Paper Venue:</strong> Vaccine: X</p>
                <p><strong>Paper TL;DR:</strong> Declining population immunity following trivalent OPV withdrawal in Pakistan is documents, and wide heterogeneity in the population impact of supplementary immunization campaigns is documented, emphasizing the importance of immunization campaign coverage for type 2 outbreak response in the final stages of polio eradication.</p>
                <p><strong>Cost:</strong> 0.002</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <p class="empty-note">No extracted data.</p>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <p class="empty-note">No potentially relevant new papers extracted.</p>
        </div>

        </div>

    </div>
</body>
</html>